These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32351189)

  • 1. Current and Future of Alzheimer's Therapy with the Best Approach.
    Singh H; Chawla V; Bala R; Dureja H
    CNS Neurol Disord Drug Targets; 2020; 19(9):691-697. PubMed ID: 32351189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.
    Salomone S; Caraci F; Leggio GM; Fedotova J; Drago F
    Br J Clin Pharmacol; 2012 Apr; 73(4):504-17. PubMed ID: 22035455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
    Francis PT; Nordberg A; Arnold SE
    Trends Pharmacol Sci; 2005 Feb; 26(2):104-11. PubMed ID: 15681028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer's Disease.
    Michalska P; Buendia I; Del Barrio L; Leon R
    Curr Top Med Chem; 2017; 17(9):1027-1043. PubMed ID: 27697052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
    Standridge JB
    Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatments in Alzheimer's disease.
    Briggs R; Kennelly SP; O'Neill D
    Clin Med (Lond); 2016 Jun; 16(3):247-53. PubMed ID: 27251914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil: potential neuroprotective and disease-modifying effects.
    Jacobson SA; Sabbagh MN
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1363-9. PubMed ID: 18798705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease.
    Schaduangrat N; Prachayasittikul V; Choomwattana S; Wongchitrat P; Phopin K; Suwanjang W; Malik AA; Vincent B; Nantasenamat C
    Med Res Rev; 2019 Sep; 39(5):1730-1778. PubMed ID: 30628099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current approaches to optimize treatment of dementia and Alzheimer's disease].
    Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):87-92. PubMed ID: 28635795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and future promise of pharmacotherapeutic strategies for Alzheimer's disease.
    Standridge JB
    J Am Med Dir Assoc; 2005; 6(3):194-9. PubMed ID: 15894249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Scaffolds as Anti- Alzheimer Agents.
    Sati B; Alka T; Chaudhary A
    Med Chem; 2023; 19(2):132-146. PubMed ID: 36043764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on huperzine A as a treatment for Alzheimer's disease.
    Little JT; Walsh S; Aisen PS
    Expert Opin Investig Drugs; 2008 Feb; 17(2):209-15. PubMed ID: 18230054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced analytical methodologies in Alzheimer's disease drug discovery.
    De Simone A; Naldi M; Tedesco D; Bartolini M; Davani L; Andrisano V
    J Pharm Biomed Anal; 2020 Jan; 178():112899. PubMed ID: 31606562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Therapy for the Treatment of Alzheimer's Disease: Recent Progress and Future Prospects.
    Shirbhate E; Patel VK; Tiwari P; Kore R; Veerasamy R; Mishra A; Rajak H
    Curr Top Med Chem; 2022; 22(22):1849-1867. PubMed ID: 36082857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
    Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
    Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer's disease therapy--theory and practice].
    Gabryelewicz T; Barcikowska M; Jarczewska DL
    Wiad Lek; 2005; 58(9-10):528-35. PubMed ID: 16529064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical evaluation of current Alzheimer's drug discovery (2018-19) & futuristic Alzheimer drug model approach.
    Dorababu A
    Bioorg Chem; 2019 Dec; 93():103299. PubMed ID: 31586701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.
    Finkel SI
    Clin Ther; 2004 Jul; 26(7):980-90. PubMed ID: 15336465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug development in Alzheimer's disease: the path to 2025.
    Cummings J; Aisen PS; DuBois B; Frölich L; Jack CR; Jones RW; Morris JC; Raskin J; Dowsett SA; Scheltens P
    Alzheimers Res Ther; 2016 Sep; 8():39. PubMed ID: 27646601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.